Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.
about
Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Rationally designed PKA inhibi ...... cerebral biodistribution of N-
@nl
Rationally designed PKA inhibi ...... yl-isoquinoline-5-sulfonamide.
@en
type
label
Rationally designed PKA inhibi ...... cerebral biodistribution of N-
@nl
Rationally designed PKA inhibi ...... yl-isoquinoline-5-sulfonamide.
@en
prefLabel
Rationally designed PKA inhibi ...... cerebral biodistribution of N-
@nl
Rationally designed PKA inhibi ...... yl-isoquinoline-5-sulfonamide.
@en
P2093
P2860
P1476
Rationally designed PKA inhibi ...... hyl-isoquinoline-5-sulfonamide
@en
P2093
Alan A Wilson
Armando Garcia
Elizabeth A Rubie
Frank J LaRonde
Jeffrey H Meyer
Neil Vasdev
P2860
P304
P356
10.1016/J.BMC.2008.03.013
P407
P577
2008-03-06T00:00:00Z